University of Queensland researchers are seeking participants diagnosed with PTSD and complex PTSD for a clinical study aimed at improving understanding of its impacts on the brain and overall ...

In a first-of-its-kind clinical study, scientists at the University of Texas at Dallas and Baylor University Medical Center have shown that patients with treatment-resistant PTSD were symptom-free up ...

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase ...

Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...

MAPS Public Benefit Corporation (MAPS PBC), the nonprofit’s clinical-stage private arm, published new data from its second multi-site, ethno-racially diverse Phase 3 clinical study of MDMA-assisted ...

Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

In 2023, Australia became the first country in the world to allow health-care professionals to use a psychedelic drug to ...

Researchers have found that cases of depression, post-traumatic stress disorder (PTSD) and lack of trust in public officials are rising roughly two-and-a-half years after a Norfolk Southern train ...